相似文献/References:
[1]柳雪琴,乃东红.体外受精中卵巢反应不良的预测及处理[J].中国计划生育和妇产科,2009,(06):0.
[2]檀大羡,牛向丽,吕福通,等.精子形态学、精子-透明质结合试验与体外受精率的相关性研究[J].中国计划生育和妇产科,2010,(02):0.
TAN Da-xian,NIU Xiang-li,LV Fu-tong,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(06):0.
[3]方伟芬,张海英.补救卵胞浆内单精子显微注射的应用进展[J].中国计划生育和妇产科,2010,(03):0.
[4]秦文松,刘英,段金良,等.体外受精-胚胎移植中受精失败的原因及补救措施[J].中国计划生育和妇产科,2011,(04):0.
QIN Wen-song,LIU Ying,DUAN Jin-liangReproduction Center,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(06):0.
[5]曾玖芝,龚衍,梁梅玉,等.精子DNA损伤对常规体外受精-胚胎移植结局的影响[J].中国计划生育和妇产科,2015,(05):0.
ZENG Jiu-zhi,GONG Yan,LIANG Mei-yu,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2015,(06):0.
[6]叶虹.高龄女性体外受精助孕的促排卵策略[J].中国计划生育和妇产科,2016,(12):1.
[7]王雪梅*,王芳,鲜红.基础卵泡刺激素/黄体生成素值预测不同年龄患者体外受精/卵胞浆内单精子注射助孕结局的价值[J].中国计划生育和妇产科,2017,(11):31.
WANG Xue-mei*,WANG Fang,XIAN Hong.The value of basal follicle stimulating hormone/luteinizing hormone in
predicting the outcomes of in-vitro fertilization/intracytoplasmic sperm
injection in different age patients[J].Chinese Journal of Family Planning & Gynecotokology,2017,(06):31.
[8]赵燕*,薛萍萍,姜宙,等.睾丸酮用于卵巢低反应患者辅助生殖治疗的
荟萃分析[J].中国计划生育和妇产科,2019,(1):34.
ZHAO Yan*,XUE Ping-ping,JIANG Zhou,et al.Testosterone pretreatment in poor responders undergoing ART:
a systematic meta-analysis[J].Chinese Journal of Family Planning & Gynecotokology,2019,(06):34.
[9]夏小凤,马子凤,胡咏梅,等.基于微信平台的健康指导在不明原因不孕症体外受精/卵胞浆内单精子显微注射技术治疗中的作用探讨[J].中国计划生育和妇产科,2020,(1):52.
XIA Xiao-feng,MA Zi-feng,HU Yong-mei,et al.Discussion on the role of health guidance based on WeChat platform in infertility of unknown reason in vitro fertilization/intracytoplasmic sperm microinjection technology treatment[J].Chinese Journal of Family Planning & Gynecotokology,2020,(06):52.